Nov. 2 (UPI) -- Indonesia became the first country to approve the U.S.-made Novavax COVID-19 vaccine for emergency use.
Novavax and partner Serum Institute of India made the announcement Monday, sparking a 16% rise in Novavax's share price on the Nasdaq.